Down-regulation of core 1 β1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 3890-3897

  Yamada, Koshi ^a   Kobayashi, Noriyoshi ^a   Ikeda, Tomomi ^a   Suzuki, Yusuke ^a   Tsuge, Toshinao ^a   Horikoshi, Satoshi ^a   Emancipator, Steven N ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

IgA1 hinge region; T cell cytokines; Th2 response; the surface IgA1 positive human B cell line

Indexed keywords

CHAPERONE; CORE 1 BETA1,3 GALACTOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN A1; MESSENGER RNA; PROTEIN COSMC; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 5; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINGE REGION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TH2 CELL;

CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; GALACTOSYLTRANSFERASES; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-4; LYMPHOMA, B-CELL; MOLECULAR CHAPERONES; RNA, MESSENGER;

EID: 78649499628     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq325     Document Type: Article

References (46)

1. Tomino Y. IgA nephropathy. From molecules to men. Contrib Nephrol 1999; 126: 1-115
2. Emancipator SN. IgA nephropathy and Henoch-Schönlein syndrome. In: Jennette JC et al. (eds). Heptinstall's Pathology of the Kidney. 5th edn. Philadelphia: Lippincott-Raven, 1998; 479-540
3. Emancipator SN, Mestecky J, Lamm ME. IgA nephropathy and related diseases. In: Ogra PL et al. (eds). Mucosal Immunology. 2nd edn. New York: Academic Press, 1999; 1365-1380
4. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-2097
5. Julian BA, Novak J. IgA nephropathy: an update. Curr Opin Nephrol Hypertens 2004; 13: 171-179
6. Mestecky J, Tomana M, Crowley-Nowick PA et al. Defective ga-lactosylation and clearance of IgA1 molecules as a possible etio-pathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172-182
7. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-474
8. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopep-tides in IgA nephropathy by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. J Am Soc Nephrol 1998; 9: 577-582
9. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969-973
10. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
11. Horie A, Hiki Y, Odani H et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis 2003; 42: 486-496
12. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interraction in IgA nephropathy. J Am Soc Nephrol 1997; 8: 915-919
13. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81
14. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760-769
15. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998; 9: 2048-2054
16. Amore A, Cirina P, Conti G et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862-1871
17. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513
18. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 2005; 68: 167-172
19. Ju T, Brewer K, D'Souza A et al. Cloning and expression of human core 1 β1,3-galactosyltransferase. J Biol Chem 2002; 277: 178-186
20. Brockhausen I, Schutzbach J, Kuhns W. Glycoproteins and their relationship to human disease. Acta Anat (Basel) 1998; 161: 36-78
21. Allen AC, Topham PS, Harper SJ et al. Leucocyte β1, 3 galactosyl-transferase activity in IgA nephropathy. Nephrol Dial Transplant 1997; 12: 701-706
22. Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase. Proc Natl Acad Sci USA 2002; 99: 16613-16618
23. Qin W, Zhou Q, Yang LC et al. Peripheral B lymphocyte β1, 3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 2005; 258: 467-477
24. Qin W, Zhong X, Fan JM et al. External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant 2008; 23: 1608-1614
25. Smith AC, de Wolff JF, Molyneux K et al. O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 2006; 17: 1192-1199
26. Malycha F, Eggermann T, Hristov M et al. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. Nephrol Dial Transplant 2009; 24: 321-324
27. Buck KS, Smith AC, Molyneux K et al. B-cell O-galactosyltransfer-ase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int 2008; 73: 1128-1136
28. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosy-lation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008-1014
29. Suzuki H, Moldoveanu Z, Hall S et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629-639
30. Hurtado A, Johnson RJ. Hygiene hypothesis and prevalence of glom-erulonephritis. Kidney Int 2005; 68: S62-S67
31. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol 1997; 159: 2327-2333
32. Chintalacharuvu SR, Nagy NU, Sigmund N et al. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001; 126: 326-333
33. Eckmann L, Morzycka-Wroblewska E, Smith JR et al. Cytokine-induced differentiation of IgA B cells: studies using an IgA expressing B-cell lymphoma. Immunology 1992; 76: 235-241
34. Xiang SD, Benson EM, Dunn IS. Tracking membrane and secretory immunoglobulin α heavy chain mRNA variation during B-cell differentiation by real-time quantitative polymerase chain reaction. Immunol Cell Biol 2001; 79: 472-481
35. Yu LM, Peng C, Starnes SM et al. Two isoforms of human membrane-bound αIg resulting from alternative mRNA splicing in the membrane segment. J Immunol 1990; 145: 3932-3936
36. Weckert HA, Hughes JA, Benson EM et al. Quantifiable analysis of human immunoglobulin heavy chain class-switch recombination to all isotypes. J Immunol Methods 2000; 233: 141-158
37. Moore JS, Kulhavy R, Tomana M et al. Reactivities of N-acetylga- lactosamine-specific lectins with human IgA1 proteins. Mol Immunol 2007; 44: 2598-2604
38. Kudo T, Iwai T, Kubota Tet al. Molecular cloning and characterization of a novel UDP-Gal:GalNAcα peptide β1, 3-glactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J Biol Chem 2002; 277: 47724-47731
39. Emancipator SN. Immunoregulatory factors in the pathogenesis of IgA nephropathy. Kidney Int 1990; 38: 1216-1229
40. Snapper CM, Mond JJ. Towards a comprehensive view of immuno-globulin class switching. Immunol Today 1993; 14: 15-17
41. Scivittaro V, Gesualdo L, Ranieri E et al. Profiles of immunoregula-tory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin Exp Immunol 1994; 96: 311-316
42. Lai KN, Leung JC, Li PK et al. Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 1991; 85: 240-245
43. Lai KN, Ho RT, Leung JC et al. CD4-positive cells from patients with IgA nephropathy demonstrate increased mRNA of cytokines that induce the IgA switch and differentiation. J Pathol 1994; 174: 13-22
44. Yano N, Endoh M, Miyazaki M et al. Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy. Clin Exp Immunol 1992; 88: 295-300
45. Van Den Wall Bake AW, Crowley-Nowick PA, Kulhavy R et al. Cytokine-induced immunoglobulin production in primary IgA ne-phropathy. Am J Kidney Dis 1992; 20: 611-617
46. Tomino Y, Sakai H, Miura M et al. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 1982; 49: 419-425 (Pubitemid 12097372)